Sign In
Buy PIRS
$13.60
+0 (+0%)
At Close: Mar 12, 2025
Best Penny Stocks To Buy Under $1.25? 3 To Watch Now
01:10pm, Thursday, 24'th Aug 2023
Are you looking for the best penny stocks to buy? You're not alone; many traders are showing a renewed interest in this exciting market.
Pieris Pharmaceuticals (PIRS) Upgraded to Strong Buy: Here's What You Should Know
01:32pm, Wednesday, 23'rd Aug 2023
Pieris Pharmaceuticals (PIRS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
New Strong Buy Stocks for August 23rd
08:16am, Wednesday, 23'rd Aug 2023
JHX, CWCO, GPI, CEG and PIRS have been added to the Zacks Rank #1 (Strong Buy) List on August 23, 2023.
Penny Stocks To Buy This Week? 4 To Watch Under $5
10:51am, Tuesday, 22'nd Aug 2023
If you're looking for penny stocks to buy this week, you've got your work cut out for yourself. Plenty of headwinds will be faced, including more tech earnings and Friday's speech from Fed Chair Jerom
Pieris (PIRS) Up On Receiving Milestone Payment From Partner
11:04am, Friday, 18'th Aug 2023
Pieris (PIRS) soars as partner Boston Pharmaceuticals initiated early-stage study of PRS-342/BOS-342, triggering an undisclosed milestone payment to the former.
BOSTON, MA / ACCESSWIRE / August 17, 2023 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company focused on novel biotherapeutics through its proprietary Anticalin® tech
New Strong Buy Stocks for August 16th
07:58am, Wednesday, 16'th Aug 2023
GM, IBN, PIRS, GPI and MBWM have been added to the Zacks Rank #1 (Strong Buy) List on August 16, 2023.
Pieris (PIRS) Pursues Strategic Alternatives, Stock Rises
09:52am, Wednesday, 19'th Jul 2023
Pieris (PIRS) announces strategic update after partner AstraZeneca terminated collaboration agreement and returned the rights to elarekibep.
Pieris Pharmaceuticals Provides Strategic Update and Announces Restructuring
09:15am, Tuesday, 18'th Jul 2023
BOSTON, MA / ACCESSWIRE / July 18, 2023 / Pieris Pharmaceuticals, Inc. (Nasdaq:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technol
3 Doomed Biotech Stocks Destined for Disaster
07:29am, Monday, 17'th Jul 2023
The world of biotech stocks is notoriously difficult to predict. History is littered with companies that appeared destined for superstar status only to crash and burn.
Pieris (PIRS) Declines as AZN Halts Study of Asthma Candidate
11:54am, Friday, 23'rd Jun 2023
Pieris' (PIRS) shares nosedive as its partner decides to discontinue a phase IIa study evaluating elarekibep for treating asthma, based on non-clinical safety data from a toxicology study.
Pieris Pharmaceuticals to Present at Jefferies 2023 Healthcare Conference
04:30pm, Friday, 02'nd Jun 2023
BOSTON, MA / ACCESSWIRE / June 2, 2023 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technol
Pieris Pharmaceuticals: Expanding Elarekibep (AZD1402) Trial Finally Has Active And Completed Sites
12:55am, Wednesday, 17'th May 2023
Expanding Elarekibep (AZD1402) trial finally has active/completed sites. Major investment risk exists because of the Company's cash burn rate.
Best Penny Stocks To Buy Now? 7 Under $1 To Watch
11:16am, Friday, 12'th May 2023
Penny stocks under $1 to watch before next week. The post Best Penny Stocks To Buy Now?
Best Penny Stocks to Buy? 3 Under $1 To Watch Before Next Week
01:23pm, Thursday, 11'th May 2023
Penny stocks under $1 to watch right now. The post Best Penny Stocks to Buy?
